(VIANEWS) – Shares of Merrimack Pharmaceuticals (NASDAQ Composite: MACK) rose 5.13% to $4.92 at 13:19 EST on Thursday, after two successive sessions in a row of gains. NASDAQ Composite is rising 1.63% to $14,809.64, following the last session’s upward trend. This seems, up until now, an all-around positive trend exchanging session today.
Merrimack Pharmaceuticals’s last close was $4.68, 50.48% under its 52-week high of $9.45.
Today’s last reported volume for Merrimack Pharmaceuticals is 6262 which is 69.85% below its average volume of 20772.
Merrimack Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was 0.23%, 0.01%, and 2.69%, respectively.
Merrimack Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.85% (last week), 3.01% (last month), and 2.69% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Merrimack Pharmaceuticals’s stock is considered to be oversold (<=20).
Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value
Merrimack Pharmaceuticals’s stock is valued at $4.92 at 13:19 EST, way below its 52-week high of $9.45 and way above its 52-week low of $3.56.
Merrimack Pharmaceuticals’s Moving Average
Merrimack Pharmaceuticals’s worth is higher than its 50-day moving average of $4.61 and way below its 200-day moving average of $5.83.
More news about Merrimack Pharmaceuticals (MACK).